🔎 Trials Near Me

መነሻ › ሊምፎማ › ማሳቹሴትስ › Boston

በBoston፣ MA ለሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለሊምፎማ የሚደረጉ 33 ጥናቶች በBoston እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Beth Israel Deaconess Medical Center - Research, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07192471

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Dana-Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07015242

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

ተሳታዮችን በመፈለግ ላይ
  • Mass General Hospital, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07013435

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

ተሳታዮችን በመፈለግ ላይ
  • Mass General Brigham, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07014293

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Dana Farber Cancer Institute., Boston
እስከ እድሜ 25 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT04094610

Epco, Zanu, Ritux for R/R FL or MZL

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Dana-Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06563596

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Boston
  • Research Site, Boston
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06137144

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Dana-Farber Cancer Institute, Boston
12 Months – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT04870944

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Boston
እድሜ ከ18 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07509151

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Massachusetts General Hospital, Boston
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT04588922

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Massachusetts General Hospital, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT04104776

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT07426484

The CARDIOPROTECT Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Beth Israel Deaconess Medical Center, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT07654426

DALY II USA/ MB-CART2019.1 for DLBCL

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Dana Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT04792489

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Call for Information (Investigational Site 0026), Boston
6 Months – 17 Years · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT02332668

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Dren Investigational Site, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁን 2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Dana-Farber Cancer Institute, Boston
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT01790152

Remote Monitoring and Symptom Management Digital Application

ተሳታዮችን በመፈለግ ላይ
  • Massachusetts General Hospital, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኤፕሪ 2026 · NCT07553572

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

ተሳታዮችን በመፈለግ ላይ
  • Massachusetts General Hospital Cancer Center, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኤፕሪ 2026 · NCT05646576

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Dana Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT03328078

Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial

ተሳታዮችን በመፈለግ ላይ
  • Dana Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06923397

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Dana-Farber Cancer Institute, Boston
እድሜ ከ18 እስከ 66 · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06859424

Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Beth Israel Deaconess Medical Center, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ማርች 2026 · NCT06510309

Odronextamab in Low Tumor Volume Advanced FL

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Beth Israel Deaconess Medical Center, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ማርች 2026 · NCT07128641

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Beth Israel Deaconess Medical Center, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ማርች 2026 · NCT06510361

A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ማርች 2026 · NCT05800366

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ፌብሩ 2026 · NCT06854003

Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ፌብሩ 2026 · NCT06475235

CONFIRM: Magnetic Resonance Guided Radiation Therapy

ተሳታዮችን በመፈለግ ላይ
  • Brigham & Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ፌብሩ 2026 · NCT04368702

Avo In R/R And Previously Untreated MCL

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ጃንዩ 2026 · NCT04855695

Mosunetuzumab for CLL MRD Clearance

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Brigham & Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ዲሴም 2025 · NCT07052695

A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Dana Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ዲሴም 2025 · NCT06986174

HEME Home Transfusion Program

ተሳታዮችን በመፈለግ ላይ
  • Brigham and Women's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2025 · NCT06487247

በሌሎች ከተሞች ለሊምፎማ የሚደረጉ ጥናቶች

በBoston ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።